Anti-KMT2B / MLL4 antibody [4C10]
5
(1 Review)
|
(5 Publications)
Mouse Monoclonal KMT2B / MLL4 antibody. Suitable for Flow Cyt, WB and reacts with Human, Recombinant fragment - Human samples. Cited in 5 publications. Immunogen corresponding to Recombinant Fragment Protein within Human KMT2B aa 800-950.
View Alternative Names
HRX2, KIAA0304, MLL2, MLL4, TRX2, WBP7, KMT2B, Histone-lysine N-methyltransferase 2B, Lysine N-methyltransferase 2B, Myeloid/lymphoid or mixed-lineage leukemia protein 4, Trithorax homolog 2, WW domain-binding protein 7, WBP-7
- Flow Cyt
Unknown
Flow Cytometry - Anti-KMT2B / MLL4 antibody [4C10] (AB56770)
Overlay histogram showing HL60 cells stained with ab56770 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab56770, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line). Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
This image was generated using the ascites version of the product.
- WB
Unknown
Western blot - Anti-KMT2B / MLL4 antibody [4C10] (AB56770)
Western blot against tagged recombinant protein immunogen using ab56770 MLL4 antibody at 1ug/ml. Predicted band size of immunogen is 36 kDa
This image was generated using the ascites version of the product.
All lanes:
Western blot - Anti-KMT2B / MLL4 antibody [4C10] (ab56770)
Predicted band size: 294 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KMT2B contributes to regulating gene expression. As part of the larger COMPASS-like complex it cooperates with other regulatory proteins to modify chromatin structure facilitating easier access of transcriptional machinery to DNA. This action influences the activation of genes important for cell differentiation and development. KMT2B interacts with several cofactors including WRAD components (WDR5 RBBP5 ASH2L and DPY30) enhancing its enzymatic activity.
Pathways
KMT2B functions prominently in signaling mechanisms like the Wnt and MAPK pathways. These pathways are integral to cell growth and differentiation. The protein intricately connects with other pathways’ proteins including beta-catenin in the Wnt pathway and ERK1/2 in the MAPK pathway. These interactions highlight KMT2B's role in regulating cellular functions and development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Cell biology and toxicology 41:52 PubMed40000487
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 63:371-383 PubMed37975495
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:350 PubMed35927251
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of oncology 2022:5054324 PubMed35578598
2022
Applications
Unspecified application
Species
Unspecified reactive species
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 22:705-722 PubMed30656427
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com